n = 72 total) in utero found no significant difference in the median rate of infection requiring treatment and/or hospitalization in the year after birth when comparing the exposed and control infants (23.6% [17/72], vs 17.4% [12/69], p = 0.36) [85]
Adems, en el estudio STEP-1036, dirigido a personas adultas con obesidad y prediabetes y en el cual se produjo una prdida de peso del 14% en el grupo de semaglutida, se observ una reversin a normoglucemia del 81%
Are GLP-1 weight-loss drugs safe for older adults?, AAMC (2025) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) Health risks of overweight and obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2023) Rybelsus, Novo Nordisk Semaglutide injection (weight management), Cleveland Clinic Semaglutide (subcutaneous route), Mayo Clinic U.S
You drew 10 units but cannot remember which vial you used
